Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

Hypha Labs (FUNI) Other Non-Current Liabilities (2018 - 2025)

Hypha Labs filings provide 5 years of Other Non-Current Liabilities readings, the most recent being $80000.0 for Q3 2025.

On a quarterly basis, Other Non-Current Liabilities changed N/A to $80000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $80000.0, a N/A change, with the full-year FY2025 number at $80000.0, changed N/A from a year prior.
Other Non-Current Liabilities hit $80000.0 in Q3 2025 for Hypha Labs, up from $30000.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $1.7 million in Q1 2021 to a low of $30000.0 in Q1 2025.